通过纵向生物标志物注册的未知时间起源的时间到事件分析
Tianhao Wang1, Sarah J Ratcliffe2, Wensheng Guo3
1Department of Neurological Sciences, and Faculty Statistician, Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612.
Journal of the American Statistical Association
|September 29, 2023
概括
本研究引入了一种灵活的半参数模型,用于分析未知开始时间的时间到事件数据,改进了传统方法. 新方法提供了对疾病进展和生存结果的公正估计和增强的预测.
科学领域:
- 生物统计学 生物统计学
- 流行病学 流行病学
- 纵向数据分析 纵向数据分析
背景情况:
- 在时间对事件分析中,观察性研究往往面临着未知时间起源 (例如疾病发病) 的挑战.
- 目前依赖参数纵向模型的方法可能会由于刚性假设而产生偏差的推断.
- 准确估计时间起源对于可靠的生存分析至关重要.
研究的目的:
- 开发一个灵活的半参数曲线注册模型,用于未知开始时间的时间到事件分析.
- 共同建模纵向和生存数据,整合未知的时间来源以进行公正的估计.
- 提出一种新的功能生存模型,利用注册函数作为时间到事件预测器.
主要方法:
- 引入了一个灵活的半参数曲线注册模型,假设纵向轨迹的共同形状函数.
- 个体特异性疾病进展的特点是随机曲线注册函数,将未知时间起源建模为随机开始时间.
- 联合概率函数整合了未知的时间起源;功能生存模型使用注册函数作为预测器.
主要成果:
- 提出的模型有助于对时间到事件参数进行公正和一致的估计.
- 功能生存模型证明了疾病进展模式的预测能力.
- 模型的非对称一致性和半参数效率在理论上已经得到证实.
结论:
- 新的半参数曲线注册方法提供了一种灵活而强大的方法来分析源不明的时间到事件数据.
- 这种方法克服了传统参数模型的局限性,在观察性研究中提供了更高的准确性.
- 模拟研究和现实数据应用证实了拟议模型的有效性和实用性.
更多相关视频
相关概念视频
Introduction To Survival Analysis
272
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
272
Assumptions of Survival Analysis
153
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
153
Comparing the Survival Analysis of Two or More Groups
218
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
218
Kaplan-Meier Approach
178
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
178
Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380


